Sanofi-aventis and Sunnybrook Health Sciences Centre Agree to Develop Treatment for Diabetic Foot UlcersResearch Agreement • June 3rd, 2022
Contract Type FiledJune 3rd, 2022The Fibrosis and Wound Repair unit is one of five Therapeutic Strategy Units created as part of sanofi- aventis’ new R&D model. Three of these units cover major pathophysiology areas where there is significant unmet medical need: immuno-inflammatory disorders, infectious disease and fibrosis and wound repair. The remaining two incorporate work in a challenging area of public health (the physiology of aging) and a high- potential geographic segment (Asia-Pacific region). The focus of the Therapeutic Strategy Units is to identify health solutions through pooling internal and external expertise and bring them to the clinic.
Bridgewater, NJ and Toronto, ON- February 15, 2011 - Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and Sunnybrook Health Sciences Centre (Toronto, Canada) announced that they have entered into a research agreement and licensing option for vasculotide,...Research Agreement • February 14th, 2011
Contract Type FiledFebruary 14th, 2011The Fibrosis and Wound Repair unit is one of five Therapeutic Strategy Units created as part of sanofi- aventis’ new R&D model. Three of these units cover major pathophysiology areas where there is significant unmet medical need: immuno-inflammatory disorders, infectious disease and fibrosis and wound repair. The remaining two incorporate work in a challenging area of public health (the physiology of aging) and a high- potential geographic segment (Asia-Pacific region). The focus of the Therapeutic Strategy Units is to identify health solutions through pooling internal and external expertise and bring them to the clinic.